Investing Profile
David H. Crean(114)
CEOVCInvestorAdvisor
General Partner at 1004 Venture Partners
San Diego, California
Your Intro Paths to David H. Crean
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →David H. Crean's investing connections
4 Investors
Connected to Alfred Lin (Sequoia Capital), Tim Chang (Mayfield Fund), Alex Kopelyan (SOSV), and 1 other investor on Signal.
Networks David H. is a member of
Robyn Frankel Network
338 CONNECTIONS
Robyn Frankel Network
338 CONNECTIONS
Robyn Frankel Network
338 CONNECTIONS
Robyn Frankel Network
338 CONNECTIONS
iCiDIGITAL Network
86 CONNECTIONS
Find David H. Crean on
cbCurrent Investing Position
1004 Venture Partners General Partner
Investment Range
$250K - $10.0M
Sweet Spot
$500K
David H. Crean is on these Sector & Stage Rankings
Diverse InvestorsPharmaceuticals (Seed)Investors who invested in diverse foundersPharmaceuticals (Series A)BioTech (Series A)Pharmaceuticals (Pre-seed)BioTech (Pre-seed)Therapeutics (Seed)Investors who invested in female foundersLos Angeles / Southern CaliforniaInvestors who were foundersDiagnostics (Seed)Drug Delivery (Seed)Diagnostics (Series A)Drug Delivery (Series A)Diagnostics (Pre-seed)Drug Delivery (Pre-seed)Therapeutics (Series A)BioTech (Seed)Therapeutics (Pre-seed)
most interested in
-Neurodegeneration (Alzheimer's/ Dementia, ALS, Parkinson's Huntinton's) -Therapeutic approaches: Vaccines, Antibodies, Small molecules, peptides, RNA -Companion Diagnosticsnot interested in
Medical devicesDavid H. Crean's Experience
Senior Manager, Medical Research Robyn FrankelPresent
Director, Project and Portfolio Management AllerganPresent
Senior Director, Corporate Business Development AllerganPresent
Vice President, Corporate Development Aqua Pharmaceuticals, an Almirall CompanyPresent
Chief Business Officer Amydis, Inc.Present
Board Advisor Robyn FrankelPresent
Board Advisor Amydis, Inc.Present
Chief Executive Officer Robyn FrankelPresent
Chief Business Officer Robyn FrankelPresent
Venture Partner 1004 Venture PartnersPresent
Managing Partner Cardiff Advisory LLCPresent
Chief Business Officer, Head of Investor & Public Relations and Communications MediciNova, Inc.Present
Board of Governor's | Chairman, Capital Development (Partnering & Fundraising) BiocomPresent
Chairman of the Board of Directors Paracrine, Inc.Present
Co-Founder, Healthcare and Life Sciences CEOthreesixtyPresent
Forum Leader - Life Sciences and Healthcare REFPresent
Post-Doctoral Research Fellowship ROSWELL PARK CANCER INSTITUTEPresent
Post-Doctoral Research Fellowship University of TorontoPresent
Senior Manager, Medical Research iCiDIGITALPresent
Board Advisor iCiDIGITALPresent
Chief Executive Officer, Board of Directors Seagull FilmsPresent
Managing Director Objective, Investment Banking & ValuationPresent
Senior Advisor Objective, Investment Banking & ValuationPresent
Chief Executive Officer iCiDIGITALPresent
Member Board of Directors Paracrine, Inc.Present
Chief Business Officer iCiDIGITALPresent
Member Board of Directors ConnectPresent
President, Board Of Directors Association For Corporate Growth - Acg San DiegoPresent
Managing Director Objective Capital Partners, LLCPresent
Senior Advisor Objective Capital Partners, LLCPresent
Chairman, Independent Member, Board Of Directors Phoenix Molecular DesignsPresent
Chief Executive Officer Lenire BiosciencesPresent
Chair, CEO Roundtable Connection - Life Sciences Procopio, Cory, Hargreaves & Savitch LLPPresent
Member Board of Directors California Life Sciences (CLS)Present
Venture Partner VU Venture PartnersPresent
Co-Founder and Forum Leader CEOthreesixtyPresent
Partner 1004 Venture PartnersPresent
Member, CEO Forum REFPresent
Contributing Author, Forbes.com Forbes Los Angeles Business CouncilPresent
Chair, CEO Circle, Life Sciences and Healthcare Association For Corporate Growth - Acg San DiegoPresent
Venture Member, Cohort 2 Venture InstitutePresent
Audit Committee Chair; Governance and Compensation Committees HistogenPresent
Chairman Of The Board Of Directors HistogenPresent
Lead Independent Director, Audit and Scientific Committees HistogenPresent
Chief Business Officer ImmunogenXPresent
Member Board of Directors Almon TherapeuticsPresent
Board of Governor's | Chairman, Capital Development BiocomPresent
Chairman of the Board Paracrine, Inc.Present
Member Board of Directors Cenna BiosciencesPresent
Co-Chair, CEO Roundtable Connection - Life Sciences Procopio, Cory, Hargreaves & Savitch LLPPresent
Venture Partner LemVega™ Biotech Venture FundPresent
Co-Founder and Chair CEOthreesixtyPresent
Chief Business Officer MediciNova, Inc.Present
General Partner 1004 Venture PartnersPresent
David H. Crean's Education
Canisius College Bachelor of Science (B.S.) PreMed & Sports Medicine
University at Buffalo Master of Science (M.S.) Natural Sciences / Oncology
State University of New York at Buffalo - School of Pharmacy and Pharmaceutical Sciences Doctor of Philosophy (Ph.D.) Biophysics
University at Buffalo Pharmacy and Pharmaceutical Sciences Doctor of Philosophy (Ph.D.) Biophysics
Pepperdine Graziadio Business School Master of Business Administration (MBA) Finance
Pepperdine University M.B.A. Finance
State University of New York at Buffalo Ph.D. Biophysics
State University of New York at Buffalo M.S. Oncology
Canisius College B.S. Pre-Medicine
Founders who looked at David H. Crean's profile also looked at these Scouts & Angels